Henry Schein Future Growth

Future criteria checks 2/6

Henry Schein is forecast to grow earnings and revenue by 18.4% and 5.9% per annum respectively. EPS is expected to grow by 15.6% per annum. Return on equity is forecast to be 14.1% in 3 years.

Key information

18.4%

Earnings growth rate

15.6%

EPS growth rate

Healthcare earnings growth	16.3%
Revenue growth rate	5.9%
Future return on equity	14.1%
Analyst coverage	Good
Last updated	15 Apr 2024

Recent future growth updates

Recent updates

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Apr 14

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Aug 21

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Aug 01

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jul 09

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Jun 09

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

May 21

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

May 01

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly

Apr 10

Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)

Feb 15

Returns On Capital At Henry Schein (NASDAQ:HSIC) Have Stalled

Jan 28

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jan 10

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Dec 11

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 43% Undervaluation?

Nov 04

Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios

Aug 25

Henry Schein announces $400M increase to stock buyback plan

Aug 18

If EPS Growth Is Important To You, Henry Schein (NASDAQ:HSIC) Presents An Opportunity

Aug 09

Henry Schein Q2 2022 Earnings Preview

Aug 01

Be Wary Of Henry Schein (NASDAQ:HSIC) And Its Returns On Capital

Jul 04

Does Henry Schein (NASDAQ:HSIC) Have A Healthy Balance Sheet?

Jun 14

Henry Schein: Neutral On Valuation, Covid-19 Sales Slowdown

Jun 09

Henry Schein, Inc. (NASDAQ:HSIC) Shares Could Be 45% Below Their Intrinsic Value Estimate

May 27

Does Henry Schein (NASDAQ:HSIC) Deserve A Spot On Your Watchlist?

May 10

Investors Could Be Concerned With Henry Schein's (NASDAQ:HSIC) Returns On Capital

Apr 04

Henry Schein: A Great Play On Medical And Dental Products Trading At An Attractive Price

Mar 07

Earnings and Revenue Growth Forecasts

NasdaqGS:HSIC - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	14,854	750	818	990	8
12/31/2025	14,076	673	725	902	14
12/31/2024	13,420	611	746	961	14
12/30/2023	12,339	416	313	500	N/A
9/30/2023	12,693	445	649	786	N/A
7/1/2023	12,598	458	532	653	N/A
4/1/2023	12,528	478	428	536	N/A
12/31/2022	12,647	538	474	602	N/A
9/24/2022	12,607	638	528	625	N/A
6/25/2022	12,718	650	648	738	N/A
3/26/2022	12,655	646	656	740	N/A
12/25/2021	12,401	631	598	710	N/A
9/25/2021	12,236	626	723	783	N/A
6/26/2021	11,898	606	783	833	N/A
3/27/2021	10,615	438	544	583	N/A
12/26/2020	10,119	403	550	599	N/A
9/26/2020	9,622	591	477	542	N/A
6/27/2020	9,291	585	436	512	N/A
3/28/2020	10,054	713	683	766	N/A
12/28/2019	9,986	701	578	654	N/A
9/28/2019	9,789	488	585	655	N/A
6/29/2019	9,636	444	526	597	N/A
3/30/2019	9,504	438	648	722	N/A
12/29/2018	9,418	431	613	685	N/A
9/29/2018	10,263	304	553	629	N/A
6/30/2018	11,069	352	511	586	N/A
3/31/2018	11,812	377	449	527	N/A
12/30/2017	8,883	293	483	546	N/A
9/30/2017	12,264	554	N/A	572	N/A
7/1/2017	11,968	550	N/A	619	N/A
4/1/2017	11,782	534	N/A	668	N/A
12/31/2016	11,572	507	N/A	643	N/A
9/24/2016	11,302	498	N/A	676	N/A
6/25/2016	11,122	492	N/A	605	N/A
3/26/2016	10,879	489	N/A	536	N/A
12/26/2015	10,630	479	N/A	616	N/A
9/26/2015	10,481	482	N/A	563	N/A
6/27/2015	10,419	469	N/A	630	N/A
3/28/2015	10,405	467	N/A	621	N/A
12/27/2014	10,371	466	N/A	593	N/A
9/27/2014	10,196	457	N/A	593	N/A
6/28/2014	9,921	450	N/A	571	N/A
3/29/2014	9,697	442	N/A	647	N/A
12/28/2013	9,561	432	N/A	664	N/A
9/28/2013	9,443	420	N/A	589	N/A
6/29/2013	9,325	409	N/A	515	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HSIC's forecast earnings growth (18.4% per year) is above the savings rate (2.3%).

Earnings vs Market: HSIC's earnings (18.4% per year) are forecast to grow faster than the US market (14.7% per year).

High Growth Earnings: HSIC's earnings are forecast to grow, but not significantly.

Revenue vs Market: HSIC's revenue (5.9% per year) is forecast to grow slower than the US market (8.1% per year).

High Growth Revenue: HSIC's revenue (5.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: HSIC's Return on Equity is forecast to be low in 3 years time (14.1%).

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Henry Schein Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Henry Schein, Inc. Provides Earnings Guidance for 2023

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year of 2023

Henry Schein, Inc. Provides Sales Guidance for the Fiscal Year 2023

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year 2022

Henry Schein, Inc. Provides Earnings Guidance for the Year 2022

Henry Schein, Inc. Provides Earnings Guidance for the Year 2022

Recent updates

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Henry Schein, Inc. to Report Q1, 2024 Results on May 07, 2024

Henry Schein, Inc. Announces Appointment of Members to the Company’S Executive Management Committee

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority interest in TriMed, Inc.

Insider recently sold US$478k worth of stock

Henry Schein, Inc., Annual General Meeting, May 21, 2024

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Full year 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. Presents Comprehensive Lineup of Solutions At the 2024 Chicago Dental Society Mid Winter Meeting

Henry Schein, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire an unknown majority interest in TriMed, Inc.

Henry Schein Appoints Carole T. Faig as New Independent Director

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein, Inc. Provides Earnings Guidance for 2023

Henry Schein, Inc. announced delayed 10-Q filing

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority stake in Shield HealthCare, Inc.

Is Henry Schein (NASDAQ:HSIC) A Risky Investment?

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year of 2023

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire a majority stake in Shield HealthCare, Inc.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired a majority stake in Large Practice Sales LLC.

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Henry Schein, Inc. to Report Q2, 2023 Results on Aug 07, 2023

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Insider recently sold US$835k worth of stock

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Executive Vice Chairman & President notifies of intention to sell stock

Executive VP & COO notifies of intention to sell stock

Executive VP recently sold US$1.9m worth of stock

Executive VP notifies of intention to sell stock

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

Henry Schein, Inc. Provides Sales Guidance for the Fiscal Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) agreed to acquire SIN - Sistema de Implante Nacional S.A. from Southern Cross Group.

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly

Independent Director recently sold US$148k worth of stock

Senior VP & Chief Legal Officer notifies of intention to sell stock

Independent Lead Director recently sold US$504k worth of stock

Independent Lead Director notifies of intention to sell stock

Independent Director recently sold US$923k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Henry Schein, Inc. Reports Impairment Charge on Intangible Assets for the Fourth Quarter Ended December 31, 2022

Now 25% undervalued

Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)

Henry Schein, Inc. (NasdaqGS:HSIC) announces an Equity Buyback for $400 million worth of its shares.

Returns On Capital At Henry Schein (NASDAQ:HSIC) Have Stalled

Henry Schein, Inc. to Report Q4, 2022 Results on Feb 16, 2023

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Insider recently sold US$1.2m worth of stock

Now 21% undervalued

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 43% Undervaluation?

Henry Schein, Inc. to Report Q3, 2022 Results on Nov 01, 2022

Henry Schein, Inc. Announces its Lineup of Products and Solutions At the American Association of Oral and Maxillofacial Surgeons (AAOMS) Annual Conference in New Orleans, La. from September 12 Through September 17

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Midway Dental Supply, Inc.

Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios

Henry Schein announces $400M increase to stock buyback plan

Henry Schein, Inc. Announces the Passing of Board Member E. Dianne Rekow

If EPS Growth Is Important To You, Henry Schein (NASDAQ:HSIC) Presents An Opportunity

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year 2022

Henry Schein, Inc. Appoints Mark Hillebrandt as Chief Digital Revenue Officer